Ajax-Loading

AstraZeneca PLC - Short Term Debt

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Short-Term-Debt" stands at 6.58 Billion United States Dollars as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Short Term Debt" stands at 6.58 Billion USD. This represents a decrease of -3.95 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 319.24 percent compared to the value the year prior.
The 1 year change in percent is 319.24.
The 3 year change in percent is 17.16.
The 5 year change in percent is 83.60.
The 10 year change in percent is 140.75.

The Serie's long term average value is 2.75 Billion United States Dollars. It's latest available value, on 09/30/2025, is 139.43 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +5,165.60%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -3.95%.

Short Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Short Term Debt905,699,262,464.00
LogoJohnson & Johnson - Short Term Debt486,508,953,600.00
LogoAbbVie Inc - Short Term Debt399,570,305,024.00
LogoRoche Holding AG - Short Term Debt317,433,206,677.55
LogoNovartis AG - Short Term Debt255,096,620,580.91